In this study,the recombinant adenovirus (Ad) vector containing dual reporter gene [i.e.human transferrin receptor gene (TFRC) and firefly luciferase reporter gene] was constructed to provide a novel experimental tool for magnetic resonance (MR) and bioluminescence dual-modality molecular imaging.The cDNA of TFRC was amplified by polymerase chain reaction (PCR) and cloned into the multiple cloning site of pShuttle-CMV-CMV-Luciferase vector.After identification by SfiⅠdigestion and sequencing,pShuttle-TFRC-Luciferase vector and the adenoviral backbone vector (pAdeno) were subjected to homologous recombination.The correct recombinant plasmid was then transfected into 293 packaging cells to produce adenoviral particles and confirmed by PCR.After infection of human colorectal cancer LOVO cells with Ad-TFRC-Luciferase,the expressions of transferrin receptor (TfR) and luciferase protein were detected respectively by Western blotting and bioluminescence imaging in vitro.The results showed that TFRC gene was successfully inserted into the adenoviral shuttle vector carrying luciferase gene.DNA sequence analysis indicated that the TFRC gene sequence in the shuttle plasmid was exactly the same as that reported in GenBank.The recombinant plasmid was identified correct by restriction digestion.Ad-TFRC-Luciferase recombinant adenovirus was constructed successfully,and the virus titer was 1.6×1010 pfu/mL.Forty-eight h after dual reporter gene transfection,the expressions of TfR and luciferase protein were increased significantly (P<0.01).It was concluded that the recombinant adenovirus vector with dual reporter gene was successfully established,which may be used for in vivo tracing target cells in multimodality imaging. In this study, the recombinant adenovirus (Ad) vector containing dual reporter gene [iehuman transferrin receptor gene (TFRC) and firefly luciferase reporter gene was constructed to provide a novel experimental tool for magnetic resonance (MR) and bioluminescence dual-modality molecular imaging. The cDNA of TFRC was amplified by polymerase chain reaction (PCR) and cloned into the multiple cloning site of pShuttle-CMV-CMV-Luciferase vector. After identification by SfiI digestion and sequencing, pShuttle-TFRC-Luciferase vector and the adenoviral backbone vector (pAdeno) were subjected to homologous recombination. The correct recombinant plasmid was then transfected into 293 packaging cells to produce adenoviral particles and confirmed by PCR. After infection of human colorectal cancer LOVO cells with Ad-TFRC-Luciferase, the expressions of transferrin receptor ( TfR) and luciferase protein were detected respectively by Western blotting and bioluminescence imaging in vitro. The results showed t hat TFRC gene was successfully inserted into the adenoviral shuttle vector carrying luciferase gene. DNA sequence analysis indicated that the TFRC gene sequence in the shuttle plasmid was exactly the same as that reported in GenBank. The recombinant plasmid was identified correct by restriction digestion. Ad- TFRC-Luciferase recombinant adenovirus was constructed successfully, and the virus titer was 1.6 × 1010 pfu / mL. Forty-eight h after dual reporter gene transfection, the expressions of TfR and luciferase protein were more significantly (P <0.01) that the recombinant adenovirus vector with dual reporter gene was successfully established, which may be used for in vivo tracing target cells in multimodality imaging.